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Borrelia burgdorferi is the causative agent of Lyme disease and is found in
two different types of hosts in nature – Ixodes ticks and various mamma-
lian organisms. To initiate disease and survive in mammalian host organ-
isms, B. burgdorferi must be able to transfer to a new host, proliferate,
attach to different tissue and resist the immune response. To resist the
host’s immune response, B. burgdorferi produces at least five different
outer surface proteins that can bind complement regulator factor H (CFH)
and/or factor H-like protein 1 (CFHL-1). The crystal structures of two
uniquely folded complement binding proteins, which belong to two distinct
gene families and are not found in other bacteria, have been previously
described. The crystal structure of the CFH and CFHL-1 binding protein
CspZ (also known as BbCRASP-2 or BBH06) from B. burgdorferi, which
belongs to a third gene family, is reported in this study. The structure
reveals that the overall fold is different from the known structures of the
other complement binding proteins in B. burgdorferi or other bacteria; this
structure does not resemble the fold of any known protein deposited in the
Protein Data Bank. The N-terminal part of the CspZ protein forms a four-
helix bundle and has features similar to the FAT domain (focal adhesion
targeting domain) and a related domain found in the vinculin/a-catenin
family. By combining our findings from the crystal structure of CspZ with
previous mutagenesis studies, we have identified a likely binding surface on
CspZ for CFH and CFHL-1.
Introduction
Lyme disease is a multisystemic infection that is pri-
marily caused by five spirochete genospecies that
belong to the Borrelia burgdorferi sensu lato complex:
B. burgdorferi sensu stricto, B. garinii, B. afzelii, B. spi-
elmanii and B. bavariensis [1–3]. Ixodes ticks act as
vectors to transmit Lyme disease causing bacteria
between different mammalian hosts. Therefore,
B. burgdorferi must survive in various conditions
found in both the Ixodes ticks and mammalian hosts.
To induce an infection, the bacteria must be
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transferred from infected Ixodes ticks to mammals
during a blood meal. Upon transfer to the new host
organism, B. burgdorferi survives by resisting the
host’s immune response and then proliferates and
spreads throughout the body. To resist the host’s
immune response, B. burgdorferi binds to the major
alternative pathway complement regulator factor
H (CFH) and factor H-like protein 1 (CFHL-1)
[4]. These two regulatory proteins are part of the
alternative pathway of the complement system. They
are related glycoproteins that contain globular
domains known as Sushi domains or short consensus
repeats (SCRs) [5]. CFH (150 kDa protein) contains
20 SCR domains connected by short loop regions, and
CFHL-1 (42 kDa protein) comprises seven SCR
domains that are similar to the first seven SCR
domains found in CFH [6]. Both proteins inhibit com-
plement activation by accelerating the decay of the C3
convertase complex in the alternative pathway and act
as cofactors for factor-I-mediated cleavage of C3b [7].
By binding CFH and CFHL-1, the bacteria mimic
the action of the host’s own cells, which bind the com-
plement regulators using glycosaminoglycans and hep-
arin which are located on the cell surface, thus
avoiding the host’s complement attack [8,9].
The proteins that bind to CFH and CFHL-1 in Bor-
relia are termed complement regulator-acquiring sur-
face proteins or CRASPs [10,11]. In B. burgdorferi,
five CRASP proteins have been identified, and they
belong to three different gene families [12]. CRASPs
(or BbCRASPs in the case of B. burgdorferi) differ in
their primary and tertiary protein structures and pos-
sess different binding modes for CFH and CFHL-1.
CspA (BbCRASP-1) belongs to the PFam54 gene fam-
ily and can bind to both CFH and CFHL-1 [13]. The
crystal structure of CspA was previously determined,
and a putative binding cleft in the homodimer has
been proposed as a binding site for complement regu-
lators (PDB entry 1W33) [14,15]. CspZ (BbCRASP-2)
does not share any sequence similarities with other
proteins, including the other CRASPs expressed in
B. burgdorferi; however, this protein does have the
ability to bind both CFH and CFHL-1 [16,17]. ErpP
(BbCRASP-3), ErpC (BbCRASP-4) and ErpA (BbC-
RASP-5) belong to the OspE/F-related (Erp) protein
family. These proteins display high sequence similarity
with each other and bind only to CFH [18–20]. The
crystal structure for ErpC has been determined in
complex with CFH domains 19–20 (PDB entry 4J38)
[21].
The determination of the CspZ crystal structure
reveals a third protein family that is responsible for
the binding of CFH and CFHL-1 in B. burgdorferi,
and this analysis provides more complete insight into
the structural biology of the CRASP proteins.
Results and discussion
Crystal structure of CspZ
The final model of CspZ contains one molecule per
asymmetric unit. Most of the 214 amino acid residues
are accounted for in the protein molecule, including a
residual N-terminal glycine residue that remained after
the cleavage of the 6xHis purification tag. The electron
density map was poor in the loop region between a-
helices aB and aC, where four residues were not mod-
eled, and also in the loop between aE and aF, where
one residue was not placed.
Overall, the CspZ molecule consists of a single
domain, and the molecule appears to have a single
hydrophobic core. However, the molecule can also be
regarded as being built from two lobes, an N-terminal
lobe and a C-terminal lobe, as concluded from the
DALI and PDBEFOLD analysis [22,23].
Both lobes consist almost entirely of a-helices. The
fold for the N-terminal lobe is similar to a right-turn
four-helix bundle. However, except for aE, the a-heli-
ces are slightly bent, and there are short loops between
helices aA and aB, as well as between aC and aD,
which are usually continuous helices in a standard
four-helix bundle domain (Fig. 1).
The C-terminal lobe is made from three a-helices.
Helices aG and aH in the C-terminal lobe are oriented
in an antiparallel fashion and are connected by a short
loop region, forming a helix–turn–helix motif. The
third helix aI in the C-terminal lobe is connected to
aH by a long loop region, resulting in aC running par-
allel to aH (Fig. 1).
The N-terminal lobe is a potential binding site for
CFH and CFHL-1, as identified in previous mutagene-
sis studies and sequence comparisons with homologous
CspZ proteins that do not bind CFH and CFHL-1,
which are found in several other B. burgdorferi strains
[16,17,24,25].
Analysis of the primary sequence by the SIB BLAST
network service and INTERPROSCAN [26,27] did not
reveal any similarities with non-CspZ proteins, includ-
ing the other known CFH and/or CFHL-1 binding
proteins.
DALI server analysis (three-dimensional alignment
with other protein structures) also failed to find any
similarities with other CFH and/or CFHL-1 binding
proteins, which suggests that the fold of CspZ is
unique among the CFH/CFHL-1 binding proteins.
However, a search of the DALI server and PDBEFOLD
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[22,23] did find similarities to other proteins that have
functions unrelated to the binding of complement fac-
tors. These three-dimensional similarities were found
only in the N-terminal lobe of the CspZ protein, and
the proteins identified by the DALI server are presented
in Table 1. The similarities to the mentioned proteins
occur within a four-helix bundle recognized as a FAT
domain (focal adhesion targeting domain) or a FAT-
related domain that is found in the vinculin/a-catenin
family.
FAT domains are found in focal adhesion kinases
that are involved in integrin-mediated signaling [28].
The FAT domain plays an important role in relaying
the signals that are generated by the attachment of the
cells to the extracellular matrix. These signals are
transmitted through the integrins to cytoplasmic and
nuclear targets and regulate the migration, survival
and proliferation of the cells [28,29].
Although the three-dimensional structure of the
CspZ N-terminal lobe is similar to the aforementioned
proteins and the crystal structures can be superim-
posed, none of these molecules has regions that show
any sequence similarity to CspZ. Although the only
annotated function for CspZ is the binding of CFH/
CFHL-1, it has been shown that CspZ also binds to
several approximately 60 kDa serum proteins from dif-
ferent mammalian species, but the identities of these
proteins have not been determined [17]. Whether the
aforementioned structural similarities are relevant to
the actual function of the N-terminal lobe remains to
Fig. 1. The overall structure of CspZ. A cartoon representation of three different orientations of CspZ, rotated by 90° in the vertical plane.
The N-terminal and C-terminal lobes are shown with pink and grey backgrounds, respectively. The molecules follow a chainbow, starting
with a blue color at the N-terminus and gradually changing to red at the C-terminus. The a-helices in CspZ are labeled from A to I, starting
from the N-terminus.
Table 1. Properties and functions of proteins with similar folds to CspZ N-terminal lobe.
No. Protein Function PDB ID Z score RMSD (A)
Identity
(%) N residues
1. Breast cancer anti-estrogen
resistance protein 1 from
Homo sapiens
Serves as a docking protein involved in
tyrosine kinase based signaling related
to cell adhesion and cell migration [41]
3T6G
chain B
9.9 2.6 11 104
2. Alpha E-catenin from
Mus musculus
Cell–cell adhesion, links the
cadherin–catenin complex to the actin
cytoskeleton [42,43]
1L7C 9.9 3.0 9 103
3. Programmed cell death
protein 10 from H. sapiens
Required for normal cardiovascular
development, involved in multiple
signaling pathways, binds to paxillin
(signal transduction adaptor protein) [35,36]
3RQE 9.6 2.9 7 96
4. Vinculin from Gallus gallus Focal adhesion and adherens junctions
by binding the actin filaments [33]
1ST6 9.0 2.7 13 94
5. Talin-1 from M. musculus Adaptor protein that couples the integrin
family of cell adhesion molecules to
cytoskeletal actin [34]
2X0C 8.1 2.5 3 90
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be determined, as other functions, such as binding to
different serum proteins, the extracellular matrix or
host cells, cannot be excluded. It should be mentioned
that the CFH/CFHL-1-binding protein CspA from
B. burgdorferi is a multifunctional outer surface pro-
tein of B. burgdorferi and can bind to laminin, plas-
minogen, fibronectin, collagen and bone morphogenic
protein 2 [30]. Although only as an assumption, the
indicator that CspZ reveals structural similarities with
certain mammalian proteins involved in adhesion and
that some of the CspZ orthologs does not bind CFH/
CFHL-1, can be an indicator for another multifunc-
tional protein of B. burgdorferi.
Residues in CspZ that are potentially involved in
CFH/CFHL-1 binding
Several studies of the CspZ protein have investigated
the residues that are potentially involved in binding to
CFH/CFHL-1 [16,24,25]. With the crystal structure in
hand, it is now possible to map the binding site in
CspZ and evaluate the potential residues that were
previously shown to be involved in CFH/CFHL-1
binding.
Using the PEPSPOT analysis created from the library of
peptides representing the CspZ protein, the four regions
involved in the binding of CFH and CFHL-1 were pre-
viously identified in CspZ by Hartmann et al. [16]. The
first region spanned residues 34–52, the second region
involved residues 70–88, the third region contained resi-
dues 127–145, and the fourth region involved residues
202–226. The second region bound only to CFHL-1,
while the other regions bound both of the complement
factors. Additionally, the last 16 C-terminal residues of
CspZ were shown to be important for binding to com-
plement regulators, as the deletion of more than 16 res-
idues from the C-terminus abolished the binding. The
crystal structure of CspZ revealed that the residues in
these four regions occupy a large surface area on all
sides of the molecule, making it difficult to determine
the exact binding position of CFH/CFHL-1 in the
CspZ protein (Fig. 2A). It is possible that the SCR
domains found in CFH/CFHL-1 somehow wrap
around the CspZ molecule, forming an extensive con-
tact area between the two molecules. The loss of bind-
ing to the complement factors resulting from the
truncation of the CspZ C-terminus could be attributed
to its subsequent misfolding, as the C-terminal and N-
terminal lobes have a common hydrophobic core.
To understand the importance of the regions
described by Hartmann et al., an alanine-scanning
mutagenesis approach was used by Siegel et al., in
which the residues located in each of the four regions
were replaced with alanine to determine the role of
each specific residue in CFH/CFHL-1 binding [25].
When mutating the residues located in the second
region (residues 70–88) (Fig. 2A), the largest effect on
CFH/CFHL-1 binding was observed after the muta-
tion of residue Phe81 to alanine. Binding also
decreased when residues Gln71, Asn75, Ser79 and
Asp84 were replaced with alanine. The loss of bind-
ing capacity after replacing Phe81 with alanine might
also arise from misfolding, as Phe81 is located near
the protein core. Residues Gln71, Asn75, Ser79 and
Asp84 form hydrogen bonds with other residues and
are involved in the stabilization of the local fold
(Fig. 2B).
In the third and fourth regions, several residues that
reduced the binding of CFH/CFHL-1 were detected
by Siegel et al. In the third region (amino acids 127–
145), alanine substitution of residues Asp133, Lys136,
Lys137 and Lys 140 did not affect binding, and only a
slight decrease in CFH/CFHL-1 binding was observed
for residues Arg129, Arg139 and His130. Mutations in
the fourth region (amino acids 202–226) significantly
impaired or completely abolished the binding of CFH/
CFHL-1. Inspection of the fourth region in the crystal
structure of CspZ revealed that the residues are largely
located on the surface of the protein and are presum-
ably not important for the stabilization of the overall
fold (Fig. 2B). Notably, hydrophobic residue Phe210 is
clearly located on the surface of the CspZ molecule,
and mutation of it to alanine resulted in significantly
reduced binding to CFH/CFHL-1. The presence of
hydrophobic residues on the surface of the protein
molecule decreases the conformational stability of the
protein because it disrupts the hydration structure that
is mediated by hydrogen bonds on the surface of the
molecule [31]. Therefore, this residue probably meets a
functional need and may be involved in the binding of
CFH/CFHL-1. Replacement of the hydrophilic residue
Arg204 with alanine resulted in a significant reduction
in CFH/CFHL-1 binding; this residue is also located
on the surface of the CspZ molecule and could be
involved in CFH/CFHL-1 binding. Alanine substitu-
tion of residues Arg206, Tyr207 and Glu214 resulted
in significantly impaired binding to CFH/CFHL-1,
and these residues are most probably not involved in
CFH/CFHL-1 binding but rather participate in hydro-
gen bonding with other nearby residues to stabilize the
local fold of the CspZ protein. For example, Tyr207
forms hydrogen bonds with Glu186 and Arg206, and
Arg206 forms a hydrogen bond with Cys187 from a-
helix H (Fig. 2C).
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Differences between homologous proteins
Some CspZ orthologs from B. burgdorferi and CspZ
proteins from B. garinii and B. afzelii do not bind
CFH/CFHL-1 [17,24]. One reason why CspZ proteins
from B. garinii and B. afzelii do not bind CFH/CFHL-
1 was thought to be associated with the presence of
approximately 40 additional residues at the N-terminus.
However, later investigations showed that the N-termi-
nal extension does not influence ligand binding in CspZ
[17]. The protein sequences from B. burgdorferi B31
and B. burgdorferi B408, which can bind CFH/CFHL-
1, were compared with the sequences of B. garinii IP89,
B. burgdorferi BL224 and B. burgdorferi B379, which
cannot bind CFH/CFHL-1. The primary sequence
diversity between these two protein groups may indi-
cate that the loop region between a-helices aB and aC
(residues 69–71 in B. burgdorferi B31) is involved in the
binding of CspZ to CFH/CFHL-1, which is in agree-
ment with previously reported results [24] (Fig. 3).
However, in addition to the differences observed in the
loop region, several differences appear in the sequence
alignment between the homologous proteins. Nearly all
of the divergent residues occur in only one or two of
the three homologous proteins that do not bind CFH/
CFHL-1 that were used in the sequence alignment,
while the other homolog has the same residue as the
proteins that are capable of CFH/CFHL-1 binding.
Although this result indicates that those residues are
not related to CFH/CFHL-1 binding, residues Ser72,
Asp133 and Lys136, which were found to be different
between the homologous proteins, were also checked
by alanine mutagenesis by Siegel et al., and the results
of that study further validate that these residues are not
involved in CFH/CFHL-1 binding [25].
A
B C
Fig. 2. Potentially relevant residues for CFH/CFHL-1 binding in CspZ. (A) Regions involved in CFH/CFHL-1 binding as found by Hartmann
et al. using PEPSPOT analysis. The molecule is presented in three different orientations, rotated by 90° in the vertical plane. The residues
belonging to the first region are colored red, the second region yellow, the third region blue and the fourth region green. (B) The residues
involved in CFH/CFHL-1 binding in CspZ as found by Siegel et al. using the alanine-scanning approach. The coloring and orientation of the
molecule are the same as in (A). (C) Location of residues Arg206, Tyr207 and Glu214 that showed significantly impaired binding to CFH/
CFHL-1 after substitution to alanine reveals their importance in fold stabilization by hydrogen bonding with nearby residues.
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Putative location of CFH/CFHL-1 binding site in
CspZ
Apart from the loop region, which differs between
homologous proteins and most probably forms a bind-
ing site in CspZ, residue Asn51 has also been found to
vary among the homologous proteins that can bind
CFH/CFHL-1 and those that cannot. Together, the
loop region between a-helices aB and aC (residues 69–
71 in B. burgdorferi B31), Asn51 and Phe210, Tyr211
and Arg204 from the fourth region (amino acids 202–
226) are all located on one side of the CspZ molecule;
jointly, these residues may form the binding site for
CFH/CFHL-1 (Fig. 4).
Binding sites within CFH and CFHL-1 required for
binding of CspZ
It has been shown that CspZ binds to CFH and
CFHL-1 through SCR domains 6 and 7 of CHF/
CHFL-1 [10]. Two peptides corresponding to SCR6
(residues 333–351) and SCR7 (residues 393–414) have
been identified in CFH and CFHL-1 using a peptide
library representing SCR domains 5–7 [16]. These pep-
tides displayed strong CspZ binding ability and were
thought to be located in the binding site of CFH and
CFHL-1 [10,16]. However, in our studies the two syn-
thetic peptides did not show any binding to CspZ as
probed by one-dimensional proton NMR spectros-
copy. No changes, such as peptide signal broadening
or chemical shift perturbations, were observed in the
spectra after CspZ addition that would indicate bind-
ing of the peptides to the protein. Additionally, co-
crystallization of CspZ with the respective peptides
produced structures that were identical to CspZ alone,
with no apparent electron density for the peptides
(data not shown). Thus, our data suggest that the
binding of the SCR6 and SCR7 peptides to CspZ is
either very weak (high micromolar or weaker) or that
environmental conditions can significantly influence
the binding affinity, since the ligand affinity blot was
23 43 63 77 97 107 117 67 33 53 87 127 













Fig. 3. Sequence alignments of the orthologous CspZ proteins that can bind to CFH/CFHL-1 (B. burgdorferi B31 and B. burgdorferi B408)
and those that cannot bind to CFH/CFHL-1 (B. garinii IP89, B. burgdorferi BL224 and B. burgdorferi B379). The residues that are different
for at least one orthologous protein but are not considered to be involved in CFH/CFHL-1 binding are colored grey. The residues proposed to
be involved in CFH/CFHL-1 binding are colored red. The numbering above the alignment corresponds to the CspZ residue numbers from
B. burgdorferi B31. Secondary structure elements for CspZ from B. burgdorferi B31 are shown below the alignment, whereas the a-helices
are indicated as cylinders and loop regions as lines.
Fig. 4. Putative CspZ binding site. The
potential binding site in CspZ includes
residue Asn51 (red color), residues in the
loop region between a-helices aB and aC
(residues 59–68 colored in blue) and
residues Arg204, Phe210 and Tyr211
(colored green) in the fourth region
(residues 202–226).
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carried out on a cellulose membrane while our studies
were performed in solution.
Materials and methods
Cloning and expression of native and Se-Met-
labeled CspZ
The CspZ gene from B. burgdorferi strain B31 was PCR-
amplified from the genomic DNA. The predicted sequence
coding for the signal peptide (residues 1–27) was excluded
from the amplified product that was cloned into the
pETm_11 expression vector (EMBL) encoding an N-termi-
nal 6xHis tag followed by a TEV (tobacco etch virus) pro-
tease cleavage site. The plasmid was transformed into
Escherichia coli RR1 cells and grown overnight at 37 °C on
LB agar plates containing kanamycin. Colonies were inocu-
lated into LB medium containing kanamycin and grown at
37 °C for another 24 h. Plasmid DNA was isolated from
the resulting culture and verified by DNA sequencing. The
plasmid was transformed in E. coli BL21 (DE3) cells and
grown in modified 2xTYP medium [supplemented with
kanamycin (10 mgmL1), 133 mM phosphate buffer (pH
7.4) and glucose (4 gL1)] with vigorous agitation at 25 °C
until an A600 of 0.8–1.0. It was then induced with 0.2 mM
isopropyl thio-b-D-galactoside and grown for an additional
16–20 h.
L-Selenomethionine (Se-Met) labeled protein was
expressed in E. coli B834 (DE3). The cells were grown in
modified 2xTYP medium [supplemented with 133 mM
phosphate buffer (pH 7.4) and glucose (2 gL1)] until an
A of 1.0 was reached. The cells were then centrifuged,
and the resulting pellet was resuspended in 0501 medium
(without methionine; Athena Enzyme Systems, Baltimore,
USA) supplemented with 0502 medium (Athena Enzyme
Systems) and glucose (5 gL1), and they were grown for
an additional 2 h. Finally, 0.5 mM isopropyl thio-b-D-
galactoside and a mixture of Se-Met:Met (5 : 1) was
added, and the cultivation was continued for 20 h. The
incorporation of Se-Met was verified by mass spectrome-
try as described previously [32].
Protein purification and 6xHis tag cleavage
The cells were lysed by sonication, and the cellular debris
was removed by centrifugation. The supernatant was loaded
onto a Ni-nitrilotriacetic acid agarose (Qiagen, Hilden,
Germany) column and eluted with 300 mM imidazole, pH
7.5. The elution buffer was then exchanged for 20 mM Tris/
HCl (pH 8.0) using an Amicon centrifugal filter unit
(Millipore, Billerica, USA).
The 6xHis tag was removed by overnight incubation
with TEV protease. The protease, the digested 6xHis tag
and any remnants of uncleaved protein were subsequently
removed using an additional round of Ni-nitrilotriacetic
acid chromatography. The eluted protein fraction was
concentrated to 9 mgmL1 with an Amicon centrifugal fil-
ter unit (Millipore). The purity of the CspZ was estimated
by SDS/PAGE analysis to be > 95%.
NMR binding studies
NMR spectra were acquired at 298 K on a 600 MHz Var-
ian Unity Inova spectrometer equipped with an HCN tri-
ple-resonance pulsed-field-gradient cold probe.
The proton 1D NMR spectra of each peptide in the
absence and presence of the CspZ protein were compared
to test the binding of the peptides (Metabion International
AG, Munich, Germany). The protein and peptide stock
solutions were prepared in 10 mM Tris/HCl (pH 8.0) buffer
and then diluted in the same buffer containing 8% (v/v)
D2O for the binding studies. The NMR samples initially
contained 90 lM peptide in a total volume of 250 lL, to
which 37.5 lL of a 600 lM CspZ solution was added, yield-
ing a peptide to protein concentration ratio of 1 : 1.
Table 2. Data processing, refinement and validation statistics.
Values in parentheses are for the highest resolution bin.
Data set Se-Met Native
Space group P 21212 P 21212
Unit cell dimensions
a (A) 90.48 90.69
b (A) 48.89 48.84
c (A) 44.31 44.15
Wavelength (A) 0.9805 0.9718
Resolution (A) 33.23–2.10 45.34–1.83
Highest resolution bin (A) 2.21–2.10 1.93–1.83
No. of reflections 166 726 64 751
No. of unique reflections 12 042 17 877
Completeness (%) 100.0 (100.0) 99.8 (100.0)
Rmerge 0.10 (0.43) 0.04 (0.16)
I/r (I) 15.4 (5.7) 19.1 (7.6)
Multiplicity 13.8 (13.9) 3.6 (3.7)
Refinement
Rwork 0.190 (0.222) 0.197 (0.220)
Rfree 0.226 (0.323) 0.239 (0.249)
Average B-factor (A2)
Overall 36.9 23.7





Bond lengths (A) 0.013 0.019
Bond angles (°) 1.435 1.840
Ramachandran outliers (%)
Residues in most favored
regions (%)
97.49 97.54
Residues in allowed regions (%) 2.51 2.46
Outliers (%) 0.00 0.00
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Crystallization of CspZ
The crystallization conditions for CspZ were determined by
mixing 1 lL of protein with 1 lL of reservoir solution
from commercially available screens (Molecular Dimen-
sions Ltd, Newmarket, UK) using the sitting-drop vapor-
diffusion method. The crystals were obtained in 30% PEG
2000 MME, 0.1 M Tris/HCl (pH 8.5) and 0.2 M sodium
acetate. The Se-Met-labeled protein was crystallized in the
same conditions. As a cryoprotectant, mother liquor with
25% glycerol was used in both cases, and the crystals were
flash-frozen in liquid nitrogen.
Data collection and structure determination
The X-ray diffraction data for the native and Se-Met-
labeled protein were collected at the MAX-lab beamlines
I911-3 and I911-2 (Lund, Sweden). For the Se-Met-labeled
CspZ protein, the structure was determined using the single-
wavelength anomalous dispersion method. For the native
CspZ protein, the structure was determined by molecular
replacement using the structure of the Se-Met-labeled pro-
tein as the search model (PDB entry 4BG0). The reflections
were indexed and scaled using MOSFLM [33] and SCALA [34]
from the CCP4 suite [35]. The initial phases for Se-Met CspZ
were obtained using SHELX C/D/E [36] and PHASER for the
molecular replacement [37]. The initial protein model was
built automatically in BUCCANEER [38], and minor rebuilding
of the model was performed manually in COOT [39]. Water
molecules were automatically selected in COOT and inspected
manually. Crystallographic refinement was performed with
REFMAC5 [40]. A summary of the data collection, refinement
and validation statistics for CspZ is given in Table 2.
Accession numbers
The coordinates and structure factors for BBH06 (CspZ)
have been deposited in the Protein Data Bank with the
accession numbers 4BG0 and 4CBE.
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